pmid,title,journal,year,drug,disease
40543162,"Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods.",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2025,Nilotinib,HIV AIDS
37150084,"Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation.",European journal of medicinal chemistry,2023,Nilotinib,HIV AIDS
30142322,Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.,Biochemical pharmacology,2018,Nilotinib,HIV AIDS
19606034,Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook.,Current opinion in oncology,2009,Nilotinib,HIV AIDS
